Limited-Time September Offer: Try 7 Days for Free

Halozyme Therapeutics (0J2O.L) Stock Price

$76.67 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    8

  • Fundamental

    8

  • Technical

    6

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Halozyme Therapeutics, AI stock picks, stock alerts and much more.

Sign up

0J2O.L AI Stock Analysis

AI stock analysis for 0J2O.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Halozyme Therapeutics (0J2O.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Halozyme Therapeutics (0J2O.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Halozyme Therapeutics (0J2O.L), currently trading at $76.67, will... Sign up to access price prediction.

About 0J2O.L

LSE

  • Halozyme Therapeutics, Inc.

  • Symbol

    0J2O.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    9B

Similar Stocks

0QZU.L Vertex Pharmaceuticals Incorporated
0QZU.L		 $385
0.8%
7
0K6R.L Neurocrine Biosciences
0K6R.L		 $143.9
0.6%
6
0IGA.L Emergent BioSolutions Inc.
0IGA.L		 $8.21
3.7%
5
0H7R.L Abeona Therapeutics Inc.
0H7R.L		 $5.54
3%
4
0IIM.L Esperion Therapeutics
0IIM.L		 $2.75
0.2%
5

News

No news articles.

0J2O.L Alternative Data

Web Traffic

Halozyme Therapeutics receives an estimated 11965 monthly visitors to halozyme.com.

  • Web Traffic

    11965

  • Change from Previous Month

    36.6%

  • 3 Month Change

    8.4%

  • YoY Change

    8.4%

Twitter Followers

Halozyme Therapeutics has 640 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.3% over the last month.

  • Twitter Followers

    640

  • Daily Change

    0.2%

  • 1 Month Change

    1.3%

  • 3 Month Change

    2.9%

  • YoY Change

    2.9%

Youtube Subscribers

Halozyme Therapeutics has 80 subscribers on its main Youtube channel, up by 2.6% over the last month.

  • Youtube Subscribers

    80

  • Daily Change

    0%

  • 1 Month Change

    2.6%

  • 3 Month Change

    3.9%

  • YoY Change

    3.9%

Job Postings

Halozyme Therapeutics has an estimated 8 open job postings, which is down -20% over the last month.

  • Job Postings

    8

  • Daily Change

    0%

  • 1 Month Change

    20%

  • 3 Month Change

    38.5%

  • YoY Change

    38.5%

Reddit Mentions

Halozyme Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

21,137 are following Halozyme Therapeutics on LinkedIn, up by 0.8% over the last month.

  • LinkedIn Followers

    21137

  • Daily Change

    0.8%

  • 1 Month Change

    0.8%

  • 3 Month Change

    2.5%

  • YoY Change

    2.5%

LinkedIn Employees

According to LinkedIn, Halozyme Therapeutics has 472 employees, up by 1.5% over the last month.

  • LinkedIn Employees

    472

  • Daily Change

    1.5%

  • 1 Month Change

    1.5%

  • 3 Month Change

    0.9%

  • YoY Change

    0.9%

Business Outlook

According to employee reviews, the business outlook among employees at Halozyme Therapeutics is 73 out of 100 (bullish).

  • Business Outlook

    73

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Halozyme Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0J2O.L Financials

0J2O.L Key Metrics

  • Total Revenue

    $264.9M

  • Net Income

    $118.1M

  • Earnings per Share

    $0.96

  • Free cash flow

    $153.3M

  • EBITDA

    $168.8M

  • EBITDA Ratio

    0.637323

  • Total Assets

    $2.2B

0J2O.L 2-year Revenue & Income
0J2O.L 2-year Free Cash Flow

0J2O.L Technicals

0J2O.L SMA
0J2O.L RSI

FAQ

What's the current price of Halozyme Therapeutics (0J2O.L) Stock?
The price of an Halozyme Therapeutics (0J2O.L) share is $76.67.

What's the market cap of Halozyme Therapeutics?
The current market cap of Halozyme Therapeutics is 9B.

What are some stocks similar to Halozyme Therapeutics (0J2O.L) that investors often compare it to?
Halozyme Therapeutics (0J2O.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.

What is the forecast for Halozyme Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Halozyme Therapeutics' stock price to be around $84.3 in 2026. Starting from the current price of $76.67, this represents a 10% change in price, indicating a bullish outlook for the stock.

How to buy Halozyme Therapeutics (0J2O.L) Stock?
Halozyme Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Halozyme Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.